CLINICAL_TRIALS
trial_result
· 2023-07-24
Clinical Trial Update: An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. [Phase 2]
Summary
Phase 2 trial of LEO 138559 in adults with moderate-to-severe atopic dermatitis has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-07-24